Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.
Kobayashi K, Miyagawa N, Mitsui K, Matsuoka M, Kojima Y, Takahashi H, Ootsubo K, Nagai J, Ueno H, Ishibashi T, Sultana S, Okada Y, Akimoto S, Okita H, Matsumoto K, Goto H, Kiyokawa N, Ohara A. Kobayashi K, et al. Among authors: nagai j. Pediatr Blood Cancer. 2015 Jun;62(6):1058-60. doi: 10.1002/pbc.25327. Epub 2014 Nov 14. Pediatr Blood Cancer. 2015. PMID: 25400122
Acute lymphoblastic leukemia in a male with Simpson-Golabi-Behmel syndrome.
Minatogawa M, Iwasaki F, Yokoi T, Nagai J, Sakazume S, Goto H, Kurosawa K. Minatogawa M, et al. Among authors: nagai j. Am J Med Genet A. 2018 Jul;176(7):1680-1682. doi: 10.1002/ajmg.a.38664. Epub 2018 May 7. Am J Med Genet A. 2018. PMID: 29737011 No abstract available.
Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
Tsurusaki Y, Nagai JI, Fujita S, Sugiyama M, Nakamura W, Hayashi A, Miyagawa N, Keino D, Yokosuka T, Iwasaki F, Hamanoue S, Shiomi M, Goto S, Kurosawa K, Goto H. Tsurusaki Y, et al. Pediatr Blood Cancer. 2020 Jan;67(1):e28019. doi: 10.1002/pbc.28019. Epub 2019 Sep 25. Pediatr Blood Cancer. 2020. PMID: 31556219 No abstract available.
Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, Sakurai Y, Miyagawa N, Keino D, Yokosuka T, Iwasaki F, Hamanoue S, Shiomi M, Goto S. Goto H, et al. Among authors: nagai j. Cancer Chemother Pharmacol. 2020 Apr;85(4):773-783. doi: 10.1007/s00280-020-04045-9. Epub 2020 Mar 6. Cancer Chemother Pharmacol. 2020. PMID: 32144432
Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, Sakurai Y, Miyagawa N, Keino D, Yokosuka T, Iwasaki F, Hamanoue S, Shiomi M, Goto S. Goto H, et al. Among authors: nagai j. Cancer Chemother Pharmacol. 2021 Dec;88(6):1055-1056. doi: 10.1007/s00280-021-04321-2. Cancer Chemother Pharmacol. 2021. PMID: 34275013 No abstract available.
Using the in vitro drug sensitivity test to identify candidate treatments for transient abnormal myelopoiesis.
Yokosuka T, Ito M, Yoshino Y, Hirose A, Nakamura W, Sakurai Y, Hayashi A, Fujita S, Miyagawa N, Keino D, Iwasaki F, Hamanoue S, Yanagimachi M, Goto S, Nagai JI, Ueno H, Takita J, Tanaka Y, Taga T, Goto H. Yokosuka T, et al. Among authors: nagai ji. Br J Haematol. 2022 Feb;196(3):764-768. doi: 10.1111/bjh.17970. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816427
Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.
Hanada I, Terui K, Ikeda F, Toki T, Kanezaki R, Sato T, Kamio T, Kudo K, Sasaki S, Takahashi Y, Hayashi Y, Inukai T, Kojima S, Koike K, Kosaka Y, Kobayashi M, Imaizumi M, Mitsui T, Hori H, Hara J, Horibe K, Nagai J, Goto H, Ito E. Hanada I, et al. Among authors: nagai j. Genes Chromosomes Cancer. 2014 Nov;53(11):902-10. doi: 10.1002/gcc.22201. Epub 2014 Jul 16. Genes Chromosomes Cancer. 2014. PMID: 25044358
438 results